DrugPatentWatch Database Preview
Plazomicin sulfate - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for plazomicin sulfate and what is the scope of patent protection?
Plazomicin sulfate
is the generic ingredient in one branded drug marketed by Cipla Usa and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Plazomicin sulfate has twenty-eight patent family members in twenty-one countries.
Two suppliers are listed for this compound.
Summary for plazomicin sulfate
International Patents: | 28 |
US Patents: | 4 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Suppliers / Packagers: | 2 |
Bulk Api Vendors: | 1 |
DailyMed Link: | plazomicin sulfate at DailyMed |
US Patents and Regulatory Information for plazomicin sulfate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cipla Usa | ZEMDRI | plazomicin sulfate | SOLUTION;INTRAVENOUS | 210303-001 | Jun 25, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Cipla Usa | ZEMDRI | plazomicin sulfate | SOLUTION;INTRAVENOUS | 210303-001 | Jun 25, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
Cipla Usa | ZEMDRI | plazomicin sulfate | SOLUTION;INTRAVENOUS | 210303-001 | Jun 25, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
Cipla Usa | ZEMDRI | plazomicin sulfate | SOLUTION;INTRAVENOUS | 210303-001 | Jun 25, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for plazomicin sulfate
Country | Patent Number | Estimated Expiration |
---|---|---|
Cyprus | 1118915 | Start Trial |
Mexico | 2010005632 | Start Trial |
Poland | 2217610 | Start Trial |
Israel | 205880 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |